Skip to content

Main Navigation

Logo Vor BiopharmaNavigate to Vor Bio Medical Affairs homepage
  • Our Areas of Focus
    • Myasthenia Gravis (MG)
    • Sjögren’s
Disease (SjD)
  • Medical Congress Events
  • Publications
  • Sponsorships & Grants
  • Medical Information

Events

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM 2025)

•

American College of Rheumatology (ACR 2025)

•

American Academy of Neurology (AAN 2025)

•

American Academy of Neurology (AAN 2026)

•

Congress of Clinical Rheumatology – West (CCR West 2026)

•

Congress of Clinical Rheumatology – East (CCR East 2026)

•

American College of Rheumatology (ACR 2026)

•

International Symposium Sjögren’s Disease (ISSJD 2026)

•

Autoimmunity 2026

•

European Congress of Rheumatology (EULAR 2026)

•

Posts navigation

  • 1
  • 2
  • »
Logo Vor Biopharma
  • Our Areas of Focus
    • Myasthenia Gravis (MG)
    • Sjögren’s
Disease (SjD)
  • Medical Congress Events
  • Publications
  • Sponsorships & Grants
  • Medical Information

© 2026 Vor Biopharma | Telitacicept is an investigational product that is not approved for use by the FDA, or any equivalent international regulator in respect of its use outside of China.

  • Privacy Policy
  • Terms of Use

By selecting “Yes,” you confirm that you are a U.S.-based healthcare professional and that you are accessing this site for scientific and medical information. This site is not intended for patients, caregivers, or non-U.S. audiences.